Chris B, Author at J+D Forecasting

J+D helps pioneering biotech launch an efficient, best-practice forecasting process

21st October 2021

A clinical-stage biotech, with a broad oncology pipeline required an improved forecasting approach to support their launch strategy and pipeline prioritisation decision-making for a novel and innovative oncology technology.

J+D Introduce the Next Generation of FC365

30th June 2021

J+D, Global Pharmaceutical Forecasting experts are excited to announce the launch of the next generation of FC365, the all-in-one, pharmaceutical forecasting platform that will transform the working practices of forecasting teams everywhere.

Tips for Forecasting Covid-19 Therapies

1st June 2021

Written March 2021. Learn more about our tips for forecasting Covid-19 therapies. Tip 1: It is best to take a patient-based approach...

Forecasting Considerations for Sizing the Opportunity in a Covid-19 World

1st June 2021

Written March 2021. Learn more about the forecasting considerations for sizing the opportunity in a Covid-19 world. Tip 1: Factor for an increase in undiagnosed patients.

THE BENEFITS OF SAAS FOR PHARMACEUTICAL FORECASTING

5th January 2022

Learn why SaaS is becoming essential within the pharmaceutical forecasting environment.

Tips for Forecasting Therapies in a Covid-19 World

1st June 2021

Written March 2021. Learn more about forecasting therapies in a Covid-19 world. Tip 1: Look at the market from a patient perspective...

EpiCube: The current challenges of data, and how to change your approach.

9th February 2021

This is a video about EpiCube, where the CEO of J+D Forecasting, David James, discusses the challenges and importance of data in response to our latest launch – EpiCube. More about EpiCube: https://jdforecasting.com/software/epicube/ The current challenges relating to data There’s lots of data out there…

Watch Video

J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market

12th August 2020

The Challenge Identify a clear, transparent, and logical way to structure a forecast model to identify the potential for a new therapy in leukaemia. The model would be complex because patients go through different stages of treatment within a single line of treatment (for example,…

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

27th July 2020

J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the release of several pharmaceutical forecasting software upgrades.

J+D Forecasting Changed the Forecasting Approach of a Global Biotech Forever

23rd July 2020

One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.

Improve Efficiencies in your Long-range/Strategic Planning.

21st July 2020

Here we offer insight into how you can improve efficiencies in your long range strategic planning by moving to cloud-based software solutions.

Best Practice Tips for Visualizing your Pharma Forecast

20th July 2020

Here we offer insight into the best practises for visualising your forecast, from thinking about your audience to interacting with data.